alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1

                                                                      EXHIBIT 11

                           CHARTER ONE FINANCIAL, INC.
                        COMPUTATION OF PER SHARE EARNINGS

<TABLE>
<CAPTION>

                                                        THREE MONTHS ENDED JUNE 30,     SIX MONTHS ENDED JUNE 30,
                                                        ----------------------------   ---------------------------
                                                            1998           1997            1998           1997
                                                            ----           ----            ----           ----
                                                              (DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
<S>                                                       <C>            <C>            <C>            <C>        
BASIC EARNINGS PER SHARE(1):
  Weighted average number of common
    shares outstanding................................    128,105,248    124,833,976    128,005,966    125,212,660
                                                        =============  =============   ============   ============

Net income............................................ $       68,361         54,988        131,894        106,871
                                                        =============  =============   ============   ============
Basic earnings per share.............................. $          .53            .44           1.03            .85
                                                        =============  =============   ============   ============

DILUTED EARNINGS PER SHARE(1):
  Weighted average number of common shares
   outstanding........................................    128,105,248    124,833,976    128,005,966    125,212,660
  Add common stock equivalents for shares
   issuable under Stock Option Plan...................      4,215,716      3,357,852      3,947,571      3,388,246
                                                        -------------  -------------   ------------   ------------
      Weighted average number of common and
      common equivalent shares outstanding............    132,320,964    128,191,828    131,953,537    128,600,906
                                                        =============  =============   ============   ============

Net income............................................ $       68,361         54,988        131,894        106,871
                                                        =============  =============   ============   ============
Diluted earnings per share............................ $          .52            .43           1.00            .83
                                                        =============  =============   ============   ============
<FN>
---------------------------

(1) Restated to reflect the 2-for-1 stock split issued on May 20, 1998.
</TABLE>



                                       24
<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   11,924
<ALLOWANCES>                                       268
<INVENTORY>                                      8,395
<CURRENT-ASSETS>                                20,769
<PP&E>                                          15,050
<DEPRECIATION>                                   3,810
<TOTAL-ASSETS>                                  34,713
<CURRENT-LIABILITIES>                           15,412
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            45
<OTHER-SE>                                       4,256
<TOTAL-LIABILITY-AND-EQUITY>                    34,713
<SALES>                                         25,809
<TOTAL-REVENUES>                                25,809
<CGS>                                           14,653
<TOTAL-COSTS>                                   28,724
<OTHER-EXPENSES>                                  (58)
<LOSS-PROVISION>                                    50
<INTEREST-EXPENSE>                                 533
<INCOME-PRETAX>                                (3,390)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,390)
<EPS-PRIMARY>                                    (.77)
<EPS-DILUTED>                                    (.77)
        


</TABLE>
#### JACOBS, A. v. SUPERINTENDENT CLARK, et al.

38 CD 2017

Commonwealth Court of Pennsylvania.

10/23/2017

Erie County Civil Division, 13063-2016

Vacated/Remanded
I 

116TH CONGRESS 

2D SESSION H. R. 8818 

To amend title 11, United States Code, to prohibit private employers to 

deny employment involving debtors in bankruptcy. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 24, 2020 

Ms. SCANLON (for herself, Mr. NADLER, and Mr. CICILLINE) introduced the 

following bill; which was referred to the Committee on the Judiciary 

A BILL 

To amend title 11, United States Code, to prohibit private 

employers to deny employment involving debtors in bankruptcy. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Ending Bankruptcy 

5 Discrimination Act of 2020’’. 

6 SEC. 2. PROTECTION AGAINST DISCRIMINATORY TREAT7 MENT. 

8 Section 525(b) of title 11, United States Code, is 

9 amended by inserting ‘‘deny employment to,’’ after 

10 ‘‘may’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 8818 IH

1 SEC. 3. EFFECTIVE DATE; APPLICATION OF AMENDMENT. 

2 (a) EFFECTIVE DATE.—Except as provided in sub3 section (b), this Act and the amendment made by this Act 

4 shall take effect on the date of the enactment of this Act. 

5 (b) APPLICATION OF AMENDMENT.—The amendment 

6 made by this Act shall not apply with respect to conduct 

7 that occurs before the date of the enactment of this Act. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
I 

116TH CONGRESS 

1ST SESSION H. R. 918 

To amend the Internal Revenue Code of 1986 to require certain tax-exempt 

organizations to include on annual returns the names and addresses 

of substantial contributors, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 30, 2019 

Mr. PRICE of North Carolina (for himself, Mr. SARBANES, Ms. SCHAKOWSKY, 

Ms. NORTON, Mr. RYAN, Mr. CARBAJAL, Mr. GARAMENDI, and Ms. 

ESHOO) introduced the following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to require 

certain tax-exempt organizations to include on annual 

returns the names and addresses of substantial contributors, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Spotlight Act’’. 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 918 IH

1 SEC. 2. INCLUSION OF CONTRIBUTOR INFORMATION ON 

2 ANNUAL RETURNS OF CERTAIN ORGANIZA3 TIONS. 

4 (a) REPEAL OF REVENUE PROCEDURE.—Revenue 

5 Procedure 2018–38 shall have no force and effect. 

6 (b) INCLUSION OF CONTRIBUTOR INFORMATION.— 

7 (1) SOCIAL WELFARE ORGANIZATIONS.—Sec8 tion 6033(f)(1) of the Internal Revenue Code of 

9 1986 is amended by inserting ‘‘(5),’’ after ‘‘para10 graphs’’. 

11 (2) LABOR ORGANIZATIONS AND BUSINESS

12 LEAGUES.—Section 6033 of such Code is amended 

13 by redesignating subsection (n) as subsection (o) 

14 and by inserting after subsection (m) the following 

15 new subsection: 

16 ‘‘(n) ADDITIONAL REQUIREMENTS FOR ORGANIZA17 TIONS DESCRIBED IN SUBSECTIONS (c)(5) AND (c)(6) OF

18 SECTION 501.—Every organization which is described in 

19 paragraph (5) or (6) of section 501(c) and which is subject 

20 to the requirements of subsection (a) shall include on the 

21 return required under subsection (a) the information re22 ferred to in subsection (b)(5).’’. 

23 (3) EFFECTIVE DATE.—The amendments made 

24 by this subsection shall apply to returns required to 

25 be filed for taxable years ending on or after Decem26 ber 31, 2018. 


pamtmann on DSKBFK8HB2PROD with BILLS
3 

•HR 918 IH

1 (c) MODIFICATION TO DISCRETIONARY EXCEP2 TIONS.—Section 6033(a)(3)(B) of the Internal Revenue 

3 Code of 1986 is amended to read as follows: 

4 ‘‘(B) DISCRETIONARY EXCEPTIONS.— 

5 ‘‘(i) IN GENERAL.—Paragraph (1) 

6 shall not apply to any organization if the 

7 Secretary made a determination under this 

8 subparagraph before July 16, 2018, that 

9 such filing is not necessary to the efficient 

10 administration of the internal revenue 

11 laws. 

12 ‘‘(ii) RECOMMENDATIONS FOR OTHER

13 EXCEPTIONS.—The Secretary may rec14 ommend to Congress that Congress relieve 

15 any organization required under paragraph 

16 (1) to file an information return from fil17 ing such a return if the Secretary deter18 mines that such filing does not advance a 

19 national security, law enforcement, or tax 

20 administration purpose.’’. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Provident Bankshares Corporation (the Company) on
Form 10-Q for the period ended March 31, 2009 as filed with the Securities and Exchange Commission (the Report), I, Dennis A. Starliper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by
Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered
by the Report.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Dennis A. StarliperDennis A. StarliperChief Financial Officer


May 11, 2009
|
|

|Energy Market and Economic Impacts of H.R. 2454, the American Clean Energy and Security Act of 2009                                                                                    
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Figure ES-3. Allowance Prices in Main ACESA Cases, 2012-2030 (2007 dollars per metric ton CO2-equivalent).  Need help, contact the National Energy Information Center at 202-586-8800).
|Figure ES-3. Allowance Prices in Main ACESA Cases, 2012-2030 (2007 dollars per metric ton CO2-equivalent).  Need help, contact the National Energy Information Center at 202-586-8800).
|Figure ES-3. Allowance Prices in Main ACESA Cases, 2012-2030 (2007 dollars per metric ton CO2-equivalent).  Need help, contact the National Energy Information Center at 202-586-8800).
E. BENJAMIN NE'LSO\l 

# llnitcd**~tatcs ~cnatc** 

The Honorable Steven Chu, Secretary U.S. Department ofEnergy 1000 Independence Avenue, S.W. Washington, DC 20585-0001

Dear Mr. Secretary: September 28,2011 720 HAHT SENATE OfTICE BtJII [liN<i WASHINtifON, DC 20510 (202) 224 65b1 FAx: (202) 228 0012
www.benno!son.snnatn.gov

I am writing to you today regarding the proposed definition ofthe U.S. Department ofEnergy's (DOE) Preliminary Technical Support Department- "Energy Efficiency Program for Consumer Products and Commercial and Industrial Equipment: Battery Charges and External Power Supplies." My concern with this proposal is the possible classification ofgolfcar battery charging systems as "consumer products," rather than commercial and industrial projects. Ifgolfcar batteries were to 

### be placed in this classification and required to meet Candidate Standard Levels (CSLs) beyond baseline (CSL-0) levels, the manufacturers ofthese batteries would likely have to move to Switch Mode technology, which requires foreign manufacturing in Asia, in order to be competitive in pricing. Such a move would put American manufacturingjobs at risk, including 100 positions in Lincoln, Nebraska, while increasing the efficiency ofthese products by no more than five percent. According to DOE regulations, the statutory definition ofa consumer product "is any article other than an automobile, as defined in section 32901(a)(3) oftitle 49, that consumes energy or water and which, to any significant extent, is distributed in commerce for personal use or consumption by individuals." Over 90 percent ofnew golfcars are sold to commercial or industrial businesses, primarily golfcourses. With less than ten percent ofthese golfcars being "distributed in commerce for personal use or consumption by individuals," they do not appear to meet the "significant extent" standard necessary to be considered a consumer product.

I would, therefore, encourage the DOE to reconsiderthe classification ofgolfcarbatteries as a consumer product. While it is certainly important to promote energy efficiency, I am sure you will agree that such changes cannot be made at the expense ofAmerican manufacturingjobs. Ifyou wish to discuss this matter further orwould like to visit with the impacted manufacturer in my home state, please do not hesitate to contact me directly, or have your staffcontact Erick Lutt ofmy staff, at 202-224-6551. I look forward to your response.

EBN:ejl**-~-to** Nln: H :;:11 ::;·ru 1.1**~\** 1?0 ); r\l

.. \l[ tlH!lOH '41):.') i).ll .J(i()()**\·~tl7·** .l/ti**H1~<1** F:1::

.. l, Rf'i'Hr :;f •

..J**P('~** r· 0fT3r 8( )I( )'1**D~-~** K1 A><w:v, Nc 68811B

(308:'**2~l3·-5B18** Sincerely,

F!l 1 D Rl t'f\J ;-'it·!\: I ArJVE PosT On :u· Box 1472 Su

..n n_;rn: n·r·. NE G93G3

i3081631··7ii14 11819 MlllACII. Hll.L •; DH:vr StJrJE 205 OMAHA, NE 68154

(402) 391 :Ji\\1 FAX: (402) 391 4725
document.write('<span class="update">  Release date: October 19, 2009<br/>  </span>')
No. 11-10290.

#### Keeling *v.*Brunsman, Warden.

C. A. 6th Cir. Certiorari denied.
No. 85-6763.

#### Lamp *v.*United States.

C. A. 5th Cir. Certiorari denied.
No. 12-5158.

#### Shields *v.*Frontier Technology LLC, dba MicroAge LLC, et al.

C. A. 9th Cir. Certiorari denied.
# C_2022284EN.01004501.xml

| 25.7.2022 | EN | Official Journal of the European Union | C 284/45 |
| --- | --- | --- | --- |

25.7.2022

EN

Official Journal of the European Union

C 284/45

---

Action brought on 17 May 2022 — Biogen Netherlands v Commission

(Case T-278/22)

(2022/C 284/62)

Language of the case: English

Parties

Applicant: Biogen Netherlands BV (Badhoevedorp, Netherlands) (represented by: C. Schoonderbeek, lawyer)

Defendant: European Commission

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of the European Commission of 13 May 2022 C(2022) 3254 (final) granting marketing authorisation under Regulation (EC) No 726/2004 (1) for ‘Dimethyl fumarate Neuraxpharm — dimethyl fumarate’, a medicinal product for human use; and |
| --- | --- |

—

annul the decision of the European Commission of 13 May 2022 C(2022) 3254 (final) granting marketing authorisation under Regulation (EC) No 726/2004 (1) for ‘Dimethyl fumarate Neuraxpharm — dimethyl fumarate’, a medicinal product for human use; and

| — | order the Commission to pay the costs. |
| --- | --- |

—

order the Commission to pay the costs.

Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.

| 1. | First plea in law, alleging failure to observe the system of Directive 2001/83/EC (2) in relation to the rules on regulatory data protection, including Article 6(1) of that Directive, and the obligations of generic applicants under Article 10(1) of that Directive. |
| --- | --- |

1.

First plea in law, alleging failure to observe the system of Directive 2001/83/EC (2) in relation to the rules on regulatory data protection, including Article 6(1) of that Directive, and the obligations of generic applicants under Article 10(1) of that Directive.

| 2. | Second plea in law, alleging failure to recognize the consequences of the Opinion of the Committee for Medicinal Products for Human Use of 11 November 2021 for the question whether the marketing authorisation for the medicinal product Fumaderm was capable of commencing a global marketing authorisation for the medicinal product Tecfidera in accordance with Article 6(1), second subparagraph, of Directive 2001/83/EC. |
| --- | --- |

2.

Second plea in law, alleging failure to recognize the consequences of the Opinion of the Committee for Medicinal Products for Human Use of 11 November 2021 for the question whether the marketing authorisation for the medicinal product Fumaderm was capable of commencing a global marketing authorisation for the medicinal product Tecfidera in accordance with Article 6(1), second subparagraph, of Directive 2001/83/EC.

---

(1)  Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ 2004, L 136, p. 1).

(2)  Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001, L 311, p. 67).

---
Exhibit 31.2  I, Dempsey Mork, certify that:  1.           I have reviewed this quarterly report for the period ended Sept. 30, 2006 on Form 10-Q of Knickerbocker Capital Corp.;  2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4.           The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:  a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  b)           Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  c)           Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and  5.           The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):  a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and  b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.  Nov. 19, 2009   /s/ Dempsey Mork Dempsey Mork Chief Financial Officer
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 16
- 1444

JACKIE DENMARK , Plaintiff

– Appellant ,

v. CPL. D. P. STARCHER, individually and in his official capacity as a Trooper with the West Virginia State Police , Defendant

– Appellee

.

Appeal from the United States District Court for the Northern District of West Virginia , at Clarksburg

. Irene M. Keeley , District Judge. ( 1:14

- cv
- 00058

- IMK

- MJA )

Submitted : March 17 , 201 7 Decided: March 31, 2017

Before WILKINSON , KING , and AGEE , Circuit Judges

.

Affirmed by un published per curiam opinion

.
Henry E. Wood, III, WOOD LAW OFFICE, LC, Charleston, West Virginia, for Appellant. Gary E. Pullin, Wendy E. Greve, PULLIN, FOWLER, FLANAGAN, BROWN & POE, PLLC, Charleston, West Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Having carefully assessed the record on appeal and the briefs of the parties, we are satisfied that oral argument would not assist the decision

- making process in this matter

. The panel has agreed to affirm the judgment of the district court on the basis of its comprehensive and well

- c rafted opinion of July 12, 2016

. See Denmark v. Starcher , No.
1:14

- cv
- 00058 (N.D. W. Va. July 12, 2016), ECF No. 91.
AFFIRMED